Contacts: Marc Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext.
Nick Kilsby, EKK PR (203) 406-8800 ext. 21
SPEAKERS TO FOCUS ON REGULATION IN THE MUSCULOSKELETAL SECTOR AND NEW
NON-FUSION TECHNOLOGIES AT TWO INVESTOR MEETINGS SPONSORED BY VISCOGLIOSI
NEW YORK--March 8, 2004--Viscogliosi Bros., LLC (VB), the leading venture
capital/private equity and merchant banking firm in the $22.4 billion
global musculoskeletal/orthopedics sector, will sponsor two meetings
in San Francisco next week for the investment community.
In an evening event on March 11, Christopher Jennings, health care advisor
to President Clinton, will address the regulatory and reimbursement
environment for new medical device technology under the recently passed
Medicare Act. He will be followed by Steve Ubl, the senior government
relations executive at AdvaMed, the lobbying group that represents the
medical device industry in Washington DC. Anthony Viscogliosi, Senior
Managing Partner of VB, will then highlight the recent breakthroughs
in non-fusion technology and provide commentary on the future of the
The following morning, on March 12, the CEOs of three venture-backed,
international spinal/non-fusion technology companies: Raymedica, Inc.,
(US); Spine Next SA, (France) and Biorthex, Inc. (Canada) will participate
in a panel discussion on market prospects with leading spine surgeons,
headed by Dr. Rudolf Bertagnoli, of Germany and Dr. Thierry Marnay.
Both events are admission free and will be held at the W Hotel, San
Francisco. The March 11 reception will begin at 5.30 pm in the Great
Room located on the third floor of the W and the March 12 reception
will begin at 7.30 am in the Industry Room located on the second floor
of the W.
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City, in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm, with a mission to create, build and finance companies founded
on innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. They have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases